Delirium in a 73-year-old man after consistent use of betahistine for years;Delirium bij een 73-jarige man najarenlang ongewijzigd gebruik van betahistine

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 47, 2004, Pages 2338-2341

  Hoenders, H J R ^a   Wilterdink, J ^a  

^a MARTINI HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETAHISTINE; HALOPERIDOL;

AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DELIRIUM; DISEASE COURSE; DIZZINESS; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; MALE; MENIERE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION;

AGED; BETAHISTINE; BLOOD-BRAIN BARRIER; CEREBRAL INFARCTION; DELIRIUM; HALOPERIDOL; HISTAMINE AGONISTS; HUMANS; MALE; MENIERE'S DISEASE;

EID: 9244239694     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lipowski ZJ. Delirium: acute confusional states. New York: Oxford University Press; 1990.
2. Mast RC van der. De standaard 'Delier bij ouderen' van het Nederlands Huisartsen Genootschap; reactie vanuit de psychiatrie. Ned Tijdschr Geneeskd 2003;147:952-5.
3. Inouye SK, Schlesinger MJ, Lydon TJ. Delirium: a symptom of how hospital care is failing older persons and a window to improve quality of hospital care. Am J Med 1999;106:565-73.
4. Armstrong SC, Cozza KL, Watanabe KS. The misdiagnosis of delirium. Psychosomatics 1997;38:433-9.
5. Ritchie J, Steiner W, Abrahamowicz M. Incidence of and risk factors for delirium among psychiatric inpatients. Psychiatr Serv 1996; 47:727-30.
6. Elie M, Cole MG, Primeau FJ, Bellavance F. Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998;13:204-12.
7. Inouye SK. Predisposing and precipitating factors for delirium in hospitalized older patients. Dement Geriatr Cogn Disord 1999;10: 393-400.
8. Mannesse CK, Cammen TJM van der. Bijwerkingen van genees-middelen bij 3 oudere patiënten: ook bij ongewijzigd medicatiegebruik. Ned Tijdschr Geneeskd 2003;147:585-7.
9. Folstein MF, Folstein S, McHugh PR. 'Mini mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychosom Res 1975;2:89-98.
10. James AL, Burton MJ. Betahistine for Ménière's disease or syndrome [Cochrane review]. The Cochrane Library. Issue 1. Chichester: Wiley; 2004.
11. Tecott LH. Monoamine neurotransmitters. In: Sadock BJ, Sadock VA, editors. Comprehensive textbook of psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 41-50.
12. Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. 8th ed. Oxford: Oxford University Press; 2003. p. 304-17.
13. Jansen PAF. Psychofarmacologie en -therapie. In: Heeren TJ, Kat MG, Stek ML, redacteuren. Handboek ouderenpsychiatrie. 2e dr. Leusden: De Tijdstroom: 2000. p. 133-6.
14. Arrang JM, Garbarg M, Quach TT, Dam Trung Tuong M, Yeramian E, Schwartz JC. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol 1985;111:73-84.
15. Cauwenberge PB van, Moor SEG de. Physiopathology of H3-receptors and pharmacology of betahistine. Acta Otolaryngol Suppl 1997;526:43-6.